EurekAlert!

Early IABP use no better than medication in cardiogenic shock due to heart failure

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Medscape

Intra-aortic Balloon Pump May Best Inotropes in Decompensated HF

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
Medscape

The Intra-aortic Balloon Pump in High-risk Percutaneous Coronary Intervention

Early inflation Balloon inflates before aortic valve closes – the left ventricle is therefore forced to empty against an inflated balloon. There is an increase in afterload, potentially raising ...
TCTMD

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...
News Medical

Study finds no benefit of early IABP use in cardiogenic shock patients

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
MedPage Today

Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i

Compared with the years 2000-2009, cardiac deaths and case fatalities in U.S. marathon and half-marathon runners have come down significantly. (JAMA) People with zero of five classic cardiovascular ...
TCTMD

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

AMSTERDAM, The Netherlands— In patients undergoing early revascularization for myocardial infarction (MI) complicated by cardiogenic shock, use of an intra-aortic balloon pump (IABP) does not reduce ...
News Medical

Intra-aortic balloon pump support reduces 30-day mortality in postinfarction VSR patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
MedPage Today

Pilot Study Hints at IABP Benefit for Some STEMI Patients

PARIS -- Intra-aortic balloon pumps (IABP) didn't significantly improve outcomes for patients with ischemia persisting well after percutaneous coronary intervention (PCI) for a large acute ST-segment ...
Nature

Extended follow-up in IABP-SHOCK II shows no reduction in all-cause mortality with IABP

In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
Healio

FDA designates intra-aortic balloon pump recall as class I

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has designated a recall of intra-aortic balloon pumps by Datascope/Getinge as class I, the ...